Inventor · disambiguated record
Franco Tzul
Also filed as: TZUL FRANCO
5 granted patents·2 pending applications·9 citations·filing 2021–2025
73Inventor score
Files withREGENERON PHARMA7
Top patents by PatentIndex Score
7 records- 0193US12066246B2Target residual moisture content for lyophilized drug productREGENERON PHARMA·Filed 2023·Granted Aug 20, 2024·2 cites·20 claims
- 0292US11525629B2Target residual moisture content for lyophilized drug productREGENERON PHARMA·Filed 2021·Granted Dec 13, 2022·4 cites·20 claims
- 0391US11713922B2Target residual moisture content for lyophilized drug productREGENERON PHARMA·Filed 2022·Granted Aug 1, 2023·3 cites·15 claims
- 0486US12449198B2Target residual moisture content for lyophilized drug productREGENERON PHARMA·Filed 2024·Granted Oct 21, 2025·0 cites·19 claims
- 0569US2025306029A1Characterization of adeno-associated virus using microchip capillary electrophoresisREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 0667US12320814B2Characterization of adeno-associated virus using microchip capillary electrophoresisREGENERON PHARMA·Filed 2021·Granted Jun 3, 2025·0 cites·9 claims
- 0762US2024352103A1Anti-fel d1 antibody formulationsREGENERON PHARMA·Filed 2024·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Franco Tzul files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →